Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRIX IRIDEX	$1.05 +10.8%	$1.03	$0.78 ▼ $2.58	$17.63M	0.69	48,130 shs	96,018 shs
NUWE Nuwellis	$0.92 -1.6%	$0.94	$0.75 ▼ $10.33	$4.00M	0.51	967,523 shs	35,605 shs
STRR Star Equity	$2.01 -2.0%	$2.17	$1.72 ▼ $5.35	$6.45M	0.87	17,940 shs	6,041 shs
VRAY ViewRay		$0.34	$0.02 ▼ $4.96	$4.59M	0.81	7.51 million shs	108.50 million shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRIX IRIDEX	+0.53%	-7.06%	-27.08%	-34.17%	-61.15%
NUWE Nuwellis	+4.44%	+3.33%	-2.11%	-23.77%	-90.64%
STRR Star Equity	0.00%	-7.87%	-2.84%	-8.07%	-53.93%
VRAY ViewRay	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IRIX IRIDEX	0.6433 of 5 stars	0.0	3.0	0.0	0.0	2.7	1.7	0.0
NUWE Nuwellis	2.5117 of 5 stars	3.5	3.0	0.0	0.0	2.7	0.0	1.3
STRR Star Equity	2.6942 of 5 stars	3.5	3.0	0.0	0.0	1.8	1.7	1.3
VRAY ViewRay	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRIX IRIDEX	0.00	N/A	N/A	N/A
NUWE Nuwellis	3.00	Buy	$17.00	1,757.92% Upside
STRR Star Equity	3.00	Buy	$5.00	148.76% Upside
VRAY ViewRay	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest VRAY, IRIX, STRR, and NUWE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/15/2025	STRR Star Equity	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.00 ➝ $5.00
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRIX IRIDEX	$48.80M	0.36	N/A	N/A	$0.59 per share	1.78
NUWE Nuwellis	$8.79M	0.46	N/A	N/A	$18.40 per share	0.05
STRR Star Equity	$57.17M	0.11	$0.33 per share	6.11	$14.63 per share	0.14
VRAY ViewRay	$105.86M	0.00	N/A	N/A	$0.45 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRIX IRIDEX	-$9.57M	-$0.43	N/A	∞	N/A	-22.79%	-192.95%	-33.97%	8/6/2025 (Estimated)
NUWE Nuwellis	-$20.21M	-$18.24	N/A	N/A	N/A	-169.54%	-28,159.25%	-207.24%	8/12/2025 (Estimated)
STRR Star Equity	$25.13M	-$3.43	N/A	N/A	N/A	-12.41%	-8.72%	-4.62%	8/12/2025 (Estimated)
VRAY ViewRay	-$107.33M	-$0.60	N/A	N/A	N/A	-104.30%	-120.48%	-42.39%	N/A

Latest VRAY, IRIX, STRR, and NUWE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q1 2025	STRR Star Equity	-$0.25	-$0.52	-$0.27	-$0.37	$16.35 million	$12.92 million
5/13/2025	Q1 2025	IRIX IRIDEX	-$0.10	-$0.10	N/A	-$0.10	$12.10 million	$11.90 million
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
3/27/2025	Q4 2024	IRIX IRIDEX	-$0.05	-$0.05	N/A	-$0.05	$12.80 million	$12.70 million
3/20/2025	Q4 2024	STRR Star Equity	-$0.17	$0.15	+$0.32	-$0.94	$14.00 million	$17.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
STRR Star Equity	N/A	N/A	N/A	N/A	N/A
VRAY ViewRay	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRIX IRIDEX	0.55	1.54	0.85
NUWE Nuwellis	N/A	2.03	1.34
STRR Star Equity	0.21	2.05	1.60
VRAY ViewRay	N/A	1.16	0.91

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRIX IRIDEX	20.10%
NUWE Nuwellis	3.13%
STRR Star Equity	3.84%
VRAY ViewRay	92.97%

Insider Ownership

Company	Insider Ownership
IRIX IRIDEX	7.30%
NUWE Nuwellis	1.60%
STRR Star Equity	33.51%
VRAY ViewRay	2.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRIX IRIDEX	120	16.79 million	15.42 million	Optionable
NUWE Nuwellis	70	4.37 million	4.26 million	Not Optionable
STRR Star Equity	460	3.21 million	2.14 million	Not Optionable
VRAY ViewRay	295	183.40 million	178.82 million	Optionable

VRAY, IRIX, STRR, and NUWE Headlines

Recent News About These Companies

Ray Martin dives into the world of death and funerals in 'The Last Goodbye'

August 1, 2024 | sbs.com.au

ViewRay Inc (VRAYQ) Earnings Dates & Reports

May 27, 2024 | investing.com

The best 4K Blu-ray players for 2024

March 24, 2024 | digitaltrends.com

VRAY Jan 2025 2.000 call

March 16, 2024 | finance.yahoo.com

VRAY Jan 2025 0.500 put

March 16, 2024 | finance.yahoo.com

VRAY Jan 2025 0.500 call

March 16, 2024 | finance.yahoo.com

VRAY Jan 2025 3.000 put

March 16, 2024 | finance.yahoo.com

Creating the Scene with V-Ray for 3ds Max

March 2, 2024 | archdaily.com

How to Supercharge Your SketchUp Renders With V-Ray Lights and Materials

February 26, 2024 | archdaily.com

ViewRay Inc VRAYQ

November 4, 2023 | morningstar.com

NUBURU Appoints Brian Knaley as new CEO

November 1, 2023 | benzinga.com

Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Let's Preserve ViewRay Technology

October 19, 2023 | tmcnet.com

Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies

October 17, 2023 | benzinga.com

ViewRay Inc (6L9.BE)

August 20, 2023 | ca.finance.yahoo.com

B. Riley Securities downgrades ViewRay Inc. (VRAY) rating to a Neutral

July 24, 2023 | knoxdaily.com

ViewRay stock to be delisted from Nasdaq and moved to OTC Exchange

July 21, 2023 | seekingalpha.com

ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets

July 21, 2023 | finance.yahoo.com

Keeping an Eye on ViewRay Inc. (VRAY) After Insider Trading Activity

July 19, 2023 | knoxdaily.com

Why ViewRay Stock Hit A New 52-Week Low Today

July 18, 2023 | benzinga.com

ViewRay, Inc.: ViewRay Files Voluntary Chapter 11 Petitions

July 18, 2023 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

VRAY, IRIX, STRR, and NUWE Company Descriptions

IRIDEX NASDAQ:IRIX

$1.05 +0.10 (+10.76%)

Closing price 03:59 PM Eastern

Extended Trading

$1.04 -0.01 (-0.48%)

As of 04:56 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Nuwellis NASDAQ:NUWE

$0.93 0.00 (-0.32%)

As of 04:00 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Star Equity NASDAQ:STRR

$2.01 -0.04 (-1.95%)

As of 03:59 PM Eastern

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

ViewRay NASDAQ:VRAY

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time